logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 11267896 B1

PDFFull Text
Date of Patent:
Mar. 08, 2022

Filed:

Nov. 13, 2018

Anti-cd71 antibodies, activatable anti-cd71 antibodies, and methods of use thereof

Applicant:

Cytomx Therapeutics, Inc., South San Francisco, CA (US);

Inventors:

Jason Gary Sagert, San Mateo, CA (US);

Kimberly Ann Tipton, San Francisco, CA (US);

Jonathan Alexander Terrett, Lexington, MA (US);

Shweta Singh, Fremont, CA (US);

Annie Yang Weaver, San Mateo, CA (US);

Luc Roland Desnoyers, San Francisco, CA (US);

Assignee:

CYTOMX THERAPEUTICS, INC., South San Francisco, CA (US);

Attorney:

Fish & Richardson P.C.

Primary Examiner:

Jessica H Roark

Int. Cl.
CPC ...
C07K 16/28 (2006.01); C07K 16/30 (2006.01); A61K 49/00 (2006.01); A61K 47/68 (2017.01); A61P 35/00 (2006.01); A61K 39/395 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
C07K 16/2881 (2013.01); A61K 39/3955 (2013.01); A61K 47/6803 (2017.08); A61K 47/6849 (2017.08); A61K 47/6851 (2017.08); A61K 49/0032 (2013.01); A61K 49/0058 (2013.01); A61P 35/00 (2018.01); C07K 16/30 (2013.01); A61K 2039/505 (2013.01); C07K 2317/24 (2013.01); C07K 2317/33 (2013.01); C07K 2317/55 (2013.01); C07K 2317/56 (2013.01); C07K 2317/73 (2013.01); C07K 2317/76 (2013.01); C07K 2317/92 (2013.01); C07K 2317/94 (2013.01); C07K 2319/00 (2013.01); C07K 2319/50 (2013.01);
Abstract

The invention relates generally to antibodies that bind CD71, activatable antibodies that specifically bind to CD71 and methods of making and using these anti-CD71 antibodies and anti-CD71 activatable antibodies in a variety of therapeutic, diagnostic and prophylactic indications.

Find Patent Forward Citations

Sagert, Jason. (2022). Anti-cd71 antibodies, activatable anti-cd71 antibodies, and methods of use thereof (U.S. Patent No. 11267896). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/11267896

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…